Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines

키워드

참고문헌 (74)

1. Shahar E, "Plasma lipid profile and incident ischemic stroke : the Atherosclerosis Risk in Communities(ARIC)study", Stroke, 34, pp.623~631 (2003)
2. Cholesterol Treatment Trialists’(CTT)Collaboration, "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials", Lancet, 376, pp.1670~1681 (2010)
3. Collins R, "Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions", Lancet, 363, pp.757~767 (2004)
4. Amarenco P, "High-dose atorvastatin after stroke or transient ischemic attack", N Engl J Med, 355, pp.549~559 (2006)
5. Amarenco P, "Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack : the Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL)trial", Stroke, 38, pp.3198~3204 (2007)
6. Amarenco P, "A comparison of two LDL cholesterol targets after ischemic stroke", N Engl J Med, 382, pp.9~ (2020)
7. Amarenco P, "Benefit of targeting a LDL(low-density lipoprotein)cholesterol <70 mg", dL during 5 years after ischemic stroke, 2020, pp.51, 1231~1239
8. Powers WJ, "Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. A guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2019, pp.50, e344~e418
9. Dimitrios Sagris, "Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: A clinical guide by the Hellenic Stroke Organization and the Hellenic Atherosclerosis Society", International Journal of Stroke, 16(6), pp.738~750 (2021), SAGE Publications[DOI]
10. Ahmed N, "Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018", Eur Stroke J, 4, pp.307~317 (2019)
11. Sillesen H, "Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis : a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL)trial", Stroke, 39, pp.3297~3302 (2008)
12. Iso H, "Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor interven158 tion trial", N Engl J Med, 320, pp.904~910 (1989)
13. Ebrahim S, "Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean National Health System prospective cohort study", BMJ, 333, pp.22~ (2006)
14. Choi-Kwon S, "Lifestyle factors and risk of stroke in Seoul, South Korea", J Stroke Cerebrovasc Dis, 7, pp.414~420 (1998)
15. Ma C, "Low-density lipoprotein cholesterol and risk of hemorrhagic stroke : a systematic review and dose-response meta-analysis of prospective studies", Curr Atheroscler Rep, 21, pp.52~ (2019)
16. Lee SH, "Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging : analysis of risk factors for multifocal signal loss lesions", Stroke, 33, pp.2845~2849 (2002)
17. Konishi M, "Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries", Stroke, 24, pp.954~964 (1993)
18. Hackam DG, "Statins and intracerebral hemorrhage : collaborative systematic review and meta-analysis", Circulation, 124, pp.2233~2242 (2011)
19. McKinney JS, "Statin therapy and the risk of intracerebral hemorrhage : a meta-analysis of 31 randomized controlled trials", Stroke, 43, pp.2149~2156 (2012)
20. Åsberg S, "Statin therapy and the risk of intracerebral haemorrhage : a nationwide observational study", Int J Stroke, 10(Suppl A100), pp.46~49 (2015)
21. Devaraj S, "Statins and biomarkers of inflammation", Curr Atheroscler Rep, 9, pp.33~41 (2007)
22. Jung JM, "Statin use in spontaneous intracerebral hemorrhage : a systematic review and meta-analysis", Int J Stroke (2015)
23. Katsanos AH, "Statin treatment and cerebral microbleeds : a systematic review and meta-analysis", J Neurol Sci, 420, pp.117224~ (2021)
24. Chen PS, "Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use", Eur J Neurol, 22, pp.773~780 (2015)
25. Pan YS, "Use of statin during hospitalization improves the outcome after intracerebral hemorrhage", CNS Neurosci Ther, 20, pp.548~555 (2014)
26. Miura K, "Clinicoradiological profile and serum lipid levels of intracerebral hemorrhage in prior statin users", Intern Med, 50, pp.1385~1391 (2011)
27. Mustanoja S, "Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage", Stroke, 44, pp.2330~2332 (2013)
28. Marseglia LM, "Hyperhomocysteinemia and MTHFR polymorphisms as antenatal risk factors of white matter abnormalities in two cohorts of late preterm and full term newborns", Oxid Med Cell Longev, 2015, pp.543134~ (2015)
29. Dufouil C, "Longitudinal study of blood pressure and white matter hyperintensities : the EVA MRI Cohort", Neurology, 56, pp.921~926 (2001)
30. Vincent Mok, "Prevention and Management of Cerebral Small Vessel Disease", 대한뇌졸중학회지, 17(2), pp.111~122 (2015), 대한뇌졸중학회
31. Zhuang FJ, "Prevalence of white matter hyperintensities increases with age", Neural Regen Res, 13, pp.2141~2146 (2018)
32. Jimenez-Conde J, "Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke", Stroke, 41, pp.437~442 (2010)
33. Schmidt R, "Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants", Stroke, 27, pp.2043~2047 (1996)
34. Longstreth WT Jr, "Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study", Stroke, 36, pp.56~61 (2005)
35. ten Dam VH, "Effect of pravastatin on cerebral infarcts and white matter lesions", Neurology, 64, pp.1807~1809 (2005)
36. Vuorinen M, "Changes in vascular risk factors from midlife to late life and white matter lesions : a 20-year follow-up study", Dement Geriatr Cogn Disord, 31, pp.119~125 (2011)
37. Caplan LR, "Intracranial branch atheromatous disease: a neglected, understudied, and underused concept", Neurology, 39, pp.1246~1250 (1989)
38. Kim JS, "Single subcortical infarction associated with parental arterial disease : important yet neglected sub-type of atherothrombotic stroke", Int J Stroke, 8, pp.197~203 (2013)
39. Nah HW, "Diversity of single small subcortical infarctions according to infarct location and parent artery disease : analysis of indicators for small vessel disease and atherosclerosis", Stroke, 41, pp.2822~2827 (2010)
40. Tang H, "Association between low-density lipoprotein cholesterol levels and proximal single subcortical infarction in comparison with distal single subcortical infarction", J Stroke Cerebrovasc Dis, 29, pp.105198~ (2020)
41. Yoon Y, "Stroke recurrence patterns are predicted by the subtypes and mechanisms of the past, non-cardiogenic stroke", Eur J Neurol, 20, pp.928~934 (2013)
42. Lv P, "Comparison of risk factor between lacunar stroke and large artery atherosclerosis stroke : a cross-sectional study in China", PLoS One, 11, pp.e0149605~ (2016)
43. Arboix A, "Recurrent lacunar infarction following a previous lacunar stroke : a clinical study of 122 patients", J Neurol Neurosurg Psychiatry, 78, pp.1392~1394 (2007)
44. Hosomi N, "The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study", EBioMedicine, 2, pp.1071~1078 (2015)
45. Martínez-Sánchez P, "The beneficial effect of statins treatment by stroke subtype", Eur J Neurol, 16, pp.127~133 (2009)
46. Heyden S, "Nonembolic occlusion of the middle cerebral and carotid arteries : a comparison of predisposing factors", Stroke, 1, pp.363~369 (1970)
47. Caplan LR, "sex and occlusive cerebrovascular disease : a review", Stroke, 17, pp.648~655 (1986)
48. Kuller L, "An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups", Am J Epidemiol, 93, pp.1~9 (1971)
49. Uehara T, "Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Evaluation by MR angiography", Cerebrovasc Dis, 8, pp.267~272 (1998)
50. Kim JS, "Risk factors and stroke mechanisms in atherosclerotic stroke : intracranial compared with extracranial and anterior compared with posterior circulation disease", Stroke, 43, pp.3313~3318 (2012)
51. Lei C, "Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke", J Stroke Cerebrovasc Dis, 23, pp.1112~1117 (2014)
52. Weber G, "Delayed experimental atherosclerotic involvement of cerebral arteries in monkeys and rabbits (light, sem and tem observations)", Pathol Res Pract, 180, pp.353~355 (1985)
53. Kurozumi T, "Permeation and deposition of fibrinogen and low-density lipoprotein in the aorta and cerebral artery of rabbits : immuno-electron microscopic study", Br J Exp Pathol, 65, pp.355~364 (1984)
54. Yang WJ, "Histological characteristics of intracranial atherosclerosis in a Chinese population : a postmortem study", Front Neurol, 8, pp.488~ (2017)
55. Chung JW, "Intensive statin treatment in acute ischaemic stroke patients with intracranial atherosclerosis : a high-resolution magnetic resonance imaging study(STAMINA-MRI Study)", J Neurol Neurosurg Psychiatry, 91, pp.204~211 (2020)
56. Miao H, "Intensive lipid-lowering therapy ameliorates asymptomatic intracranial atherosclerosis", Aging Dis, 10, pp.258~266 (2019)
57. 방오영, "Intracranial Atherosclerosis: Current Understanding and Perspectives", 대한뇌졸중학회지, 16(1), pp.27~35 (2014), 대한뇌졸중학회[DOI]
58. Mazighi M, "Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke", Stroke, 39, pp.1142~1147 (2008)
59. Ryoo S, "Branch occlusive disease : clinical and magnetic resonance angiography findings", Neurology, 78, pp.888~896 (2012)
60. Xu WH, "Plaque distribution of stenotic middle cerebral artery and its clinical relevance", Stroke, 42, pp.2957~2959 (2011)
61. Turan TN, "Treatment of atherosclerotic intracranial arterial stenosis", Stroke, 40, pp.2257~2261 (2009)
62. Ryoo S, "Differential vascular pathophysiologic types of intracranial atherosclerotic stroke : a high-resolution wall magnetic resonance imaging study", Stroke, 46, pp.2815~2821 (2015)
63. Young Jun Choi, "Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries", 대한뇌졸중학회지, 17(3), pp.238~255 (2015), 대한뇌졸중학회
64. Ahn SH, "Isolated MCA disease in patients without significant atherosclerotic risk factors : a high-resolution magnetic resonance imaging study", Stroke, 46, pp.697~703 (2015)
65. Brinjikji W, "The effects of statin therapy on carotid plaque composition and volume : a systematic review and meta-analysis", J Neuroradiol, 44, pp.234~240 (2017)
66. Mujaj B, "Statin use is associated with carotid plaque composition : the Rotterdam Study", Int J Cardiol, 260, pp.213~218 (2018)
67. Amarenco P, "Carotid atherosclerosis evolution when targeting a low-density lipoprotein cholesterol concentration <70 mg", dL after an ischemic stroke of atherosclerotic origin, 2020, pp.142, 748~757
68. Hussain MA, "Association between statin use and cardiovascular events after carotid artery revascularization", J Am Heart Assoc, 7, pp.e009745~ (2018)
69. Caplan LR, "Atherosclerotic vertebral artery disease in the neck", Curr Treat Options Cardiovasc Med, 5, pp.251~256 (2003)
70. Moossy J, "Morphology, sites and epidemiology of cerebral atherosclerosis", Res Publ Assoc Res Nerv Ment Dis, 41, pp.1~22 (1966)
71. Grundy SM, "2018 AHA", ACC, AAPA, pp.ABC, ACPM[DOI]
72. Park HK, "Statin therapy in acute cardioembolic stroke with no guidance-based indication", Neurology, 94, pp.e1984~e1995 (2020)
73. Kusznir Vitturi B, "The role of statins in cardioembolic stroke", J Clin Neurosci, 72, pp.174~179 (2020)
74. Wu YL, "Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation", Medicine (Baltimore), 96, pp.e5918~ (2017)

관련 논문AI추천